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Background: The Human T cell lymphotropic virus type 1 (HTLV-1)-associated infective dermatitis (IDH), is a chronic
relapsing dermatitis which usually presents in children older than 2 years. A total of 300 cases have been reported
worldwide (Latin America, the Caribbean and only 5 from Senegal). Neither IDH, nor its complications have been
reported from the rest of Africa. We aimed to examine the clinical and aetiological characteristics of IDH in a cohort
of South African children.
Methods: Attendees at the dermatology clinic at King Edward VIII Hospital, Durban underwent clinical examination.
After obtaining consent those suspected of IDH had specimens taken for blood counts, immunoglobulins, serum
protein electrophoresis, viral studies (including genotyping), skin swabs and stool examinations.
Results: Nineteen of 60 suspected cases recruited over 3 years met the diagnostic criteria for IDH. The male-to-
female ratio was 1:2; mean age 8 years (range 0.7 to 15). Dermatitis mostly affected the scalp (78.9%) and axilla
(73.7%); fewer children had nasal crusting (47.4%). Mean Ig A, IgG and IgM were raised, at 3.52 g/l, 22.6 g/l and
1.38 g/l, respectively. The median CD4 cell count was 1958 cells/mm3. Viral genotyping of all tested samples were
positive for the Cosmopolitan, Subtype A (HTLV-1a).
Conclusions: IDH is a distinct entity which also affects South Africans. Our patients were older at presentation and
the majority did not present with nasal crusting as has been described in other countries.Background
The human T-cell lymphotropic virus type 1 (HTLV-1)-
associated infective dermatitis (IDH) was first reported
in Carribean children; the incidence and pathogenesis
are unknown. Somewhat reminescent of seborhoeic
dermatitis, the clinical presentation of IDH is that of
severe exudative dermatitis with crusting of the scalp,
neck, axillae, groin, external ear, and retro-auricular
areas; watery nasal discharge, and/or crusting of the an-
terior nares, from about 2 years of age. We identified
fewer than 30 publications which report less than 300
cases of IDH worldwide; reviewed in [1] The largest
series reported 50 patients from Jamaica [2]. There
has only been one report of five African cases with
IDH from Senegal [3]. IDH has been linked with the* Correspondence: carol.hlela@uct.ac.za
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reproduction in any medium, provided the ordevelopment of adult T cell leukemia/lymphoma (ATLL)
and HTLV-1-associated myelopathy/paraparesis (HAM/
TSP) [4-7]. We aimed to examine the clinical and
aetiological characteristics of IDH in a cohort of South
African children.Study subjects
Following ethical approval by the Biomedical Research
Ethics Committee, University of KwaZulu Natal, we en-
rolled sixty individuals with suspected IDH, screened
using the established criteria, Table 1 [2], amongst out-
patients attending dermatology clinic at King Edward
VIII Hospital, Durban KwaZulu Natal (KZN). Where
possible, the parents and siblings of the HTLV-1 sero-
positive participants were also recruited. Written in-
formed consent was obtained from the patients for
publication of this case series and the accompanying im-
ages. A detailed dermatological examination was done.
Formal ophthalmologic and neurologic examinations were
conducted on patients who had symptoms and/or signsd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Clinical criteria for IDH diagnosis
Major Minor
1. Eczema of scalp, axillae and groin
external ear and retro-auricular
areas, eyelid margins, paranasal skin
and/or neck
1. Positive cultures for
Staphylococcus aureus and/or
Beta-haemolytic streptococcus from
the skin or anterior nares
2. Chronic watery nasal discharge
without other signs of rhinitis and/
or crusting of the anterior nares
2. Generalized fine papular rash
(in most severe cases)
3. Chronic relapsing dermatitis with
prompt response to appropriate
therapy but prompt recurrence on
withdrawal of use of antibiotic
3. Generalized lymphadenopathy
with dermatopathic lymphadenitis
4. Usual onset in early childhood 4. Anaemia
5. Human T cell lymphotropic virus
type 1 antibody seropositivity
5. Elevated erythrocyte
sedimentation rate
6. Hyperimmunoglobulinaemia
(IgD and IgE )
7. Elevated CD4 count, CD8 count,
and CD4/CD8 ratio
Four of the criteria required for diagnosis, with mandatory inclusion of 1,2 and
5; to meet criterion 1, at least two of the sites must be affected.
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Diagnosis of HAM/ TSP was made according to WHO
guidelines [8].
Methods
Blood counts, measurement of immunoglobulin levels,
serum protein electrophoresis, viral studies, skin swabs for
bacterial culture and examination of stool samples for para-
sites were done. All enrolled participants (n = 60) had
HTLV-1 and HIV-1 serological testing done. HIV-1 ser-
ology was performed using the Vironostika HIV-1 IMPVD
Microelisa system (Biomerieux, Durham, NC) with all posi-
tives samples confirmed by a second HIV ELISA test.
Serology for HTLV-1 was performed on plasma using an
enzyme-immune assay (EIA) that detects anti-HTLV-1 and
anti-HTLV-2 antibodies (Ab-Capture EIA Test System –
Ortho-Clinical Diagnostics, Inc., Rarita, New Jersey).
HTLV-1 Western blots were not available so HTLV-1 infec-
tion was confirmed by HTLV PCR. DNA was extracted
from peripheral blood mononuclear cells (PBMC) of sero-
positive patients using the QIAamp Blood kit (Qiagen Inc.,
Chatsworth, CA, U.S.A). Detection of a 318-bp product or
a 161-bp product confirmed the presence of HTLV-1 or
HTLV-2 pol respectively. To sub-type HTLV-1 a fragment
of LTR was amplified by nested PCR using primers 12P1/
SK111 and 12P5/1P1/2P3 and sequenced (n = 6) as previ-
ously described [9]. HTLV-1 proviral copy number and
beta-globin gene copy number were quantified using real-
time quantitative PCR monitored by SYBR Green I dye
incorporation in a Roche LightCycler 1.5, using the Tax
sequence-specific primers SK43 and SK44. HTLV-1 copy
number was estimated by interpolation from standard
curves and expressed as a percentage of infected PBMCs.Results
Over a 3-year period, in an outpatient setting where over
3000 patients with varying skin conditions are seen, 60
participants, were enrolled. Thirty-three patients were
HTLV-1 seropositive, nine of these were co-infected
with HIV-1. In addition to the positive clinical findings,
19 patients underwent HTLV DNA PCR and all were
confirmed HTLV-1 and therefore fulfilled the study cri-
teria for IDH. Only HTLV-1 infected IDH confirmed
subjects are included in the analysis (n = 19) and all
HIV-1/HTLV-1 co-infected patients have been excluded
from this analysis. The summary of the results is cap-
tured in Table 2. The ages at time of testing ranged from
8 months to 15 years. The median age at first presenta-
tion/ diagnosis was 8 years (IQR 7–11). The majority of
patients (52.9%) were between 6 and 10 years old, 68.4%
were female. All were Black African. The scalp (78.9%)
and axillae (73.7%) were regions most commonly af-
fected. Only nine patients (47.4%) had chronic nasal dis-
charge or crusting of the anterior nares. Lesional skin
cultures were positive for Staphylococcus aureus in
55.6% and for Streptococcal sp in 33.3%. The streptococ-
cal species were a combination of: ß-haemolytic strepto-
coccus (BHS) groups A, B, C and G, together with
Streptococcus pyogenes. The most common of these was
BHS group G. The blood count data revealed anaemia in
20% of the participants. The lymphocyte and platelet
counts were within normal ranges, but the ESR was ele-
vated at 40 mm/hr (normal range 3-9 mm/hr) in all par-
ticipants. The immunoglobulin levels that could be
measured in our laboratory were raised. The median
CD4 count was elevated, with the CD4 count percentage
of 56% (normal range 36-46% for children) while the
CD8 count fell within normal limits, and therefore CD4:
CD8 ratio was elevated. The median HTLV-1 proviral
load was 10.5% (range 1.8-29.8%). All HTLV-1 isolates
genotyped were of the Cosmopolitan, Subtype A
(HTLV-1a). Of the nine family members tested, five were
mothers of the enrolled IDH patients. Four of the 5
mothers had clinical lesions of IDH and were HTLV-1
seropositive. One mother had no features for IDH but
HTLV-1 serology was not performed. Initially patients
received short courses of antibiotics but this was associ-
ated with relapses on stopping treatment. Control was
maintained when penicillin-containing oral antibiotics
were given simultaneously with mild-to-moderate top-
ical steroids continuously for three to six months.
Discussion
HTLV-1 is endemic in KZN with a reported seropreva-
lence of 2.6% in the Ngwelezana [10] and of 3.35 in
Ubombo (Tarin, 1997) both districts within the same
province as Durban. The mean age of our cohort
(8 years) was much older than reported in the Caribbean
Table 2 IDH study summary data: summary of the
analysis of 19 IDH patients
Total enrolled n = 60*
HTLV-1 + n = 33
IDH
confirmed
n = 19
HTLV-1/HIV + n = 9
(of n = 33)
Ethnicity all black
african
HTLV-1
subtype
Cosmopolitan
(1a)
Age mean 8 years
range 8 months
−15 years (IQR
7–11)
Gender
distribution
male 68.40%
female 52.60%
Microbiology Staph Aureus 55.60%
Streptococcal
spp
33.60%
Clinical
examination
dermatological scalp (78.9%) and
axilla (73.7%)
commonest sites of
involvement
neurological no evidence for HAM/
TSP
opthalmological corneal opacities 3
(15.6%)
Immunologic
parameters
mean (normals)
g/l
IgA 3.52 (0.65-2.9)
IgG 22.6 (5.2-15.6)
IgM 1.38 (0.28-2.4)
SPEP mean (normals)
g/l
Albumin 32.5 (32–50)
Alpha 1
globulin
4.0 (1.72-3.30)
Alpha 2
globulin
11.1 (4.2-8.7)
Beta globulin 11.4 (5.2-10.5)
Gamma
globulin
26.7 (7.1-14.5)
Blood counts mean (normals)
Hb 12.3 (11.5-13.5)
g/dl
WBCC 10.1 (4-11x10^9)
Platelets 405 (150-
450x10^9)
ESR 40 (3–9 mm/hr)
Table 2 IDH study summary data: summary of the
analysis of 19 IDH patients (Continued)
CD4 count 1958 (500–1500)
cells/mm3
CD8 count 1150 (436–2278)
cells/mm3
CD4 : CD8
ratio
1.7:1
HTLV-1
proviral load
mean (range%)
10.5 (1.8-29.8)
*remaining patients (n = 27) not further analysed, majority of which had HIV
related seborrhoiec dermatitis.
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4 years. Perhaps the subtropical climate of South Africa
could explain these differences or the disease may be
less severe in the early stages resulting in late presenta-
tion. The clinical features of IDH in South Africa are
similar to that described elsewhere. However, chronic
nasal discharge and/or nasal crusting was much less
common that expected, (a mandatory criteria for diagno-
sis). These findings support the suggestion by de Oliveira
[11] and Suite et al. [12] who have contested the inclu-
sion of nasal crusting as a major criterion for the diag-
nosis of IDH. Farre et al., in their evalution of 42 cases
from Brazil, records the fact that not all but 30 of their
42 cases, from Brazil exhibited crusting of the nares
[13], raising the same issue that crusting around the
nostrils should not be mandatory in cases of IDH. There
appears to be a major difference between the disease in
South Africa and that in Senegal, Brazil and Jamaica.
Our cases had less severe IDH presentation than in
the those from Senegal where lesions were more
infective and crusted whereas the morphology of lesions
in our study was more inflammatory than infective,
(Figures 1 and 2). Complications have been reported in
30-35% of all patients with IDH [5,14]. However, the
cases in our series had a low complication rate (15.6%),
none of the cases had other HTLV-1-related complica-
tions, such as HAM/TSP nor ATLL. The inconsistency
in the presence of a generalized fine papular rash of the
original description of IDH, taken together with our
findings (the variation in presence of nasal crusting) ap-
pear to affirm Mahe and co-worker’s speculation that
there are minor variants of IDH which do not show all
the features of full-blown IDH as reported in the litera-
ture. Clusters of IDH were observed in 4 of the 9
families in this study, reinforcing the hypothesis that
HTLV-1 infection, in all but rare cases of IDH, is from
mother to child. All six viruses were of the widely preva-
lent Cosmopolitan subtype A (HTLV-1 a), consistent
with published data from KZN [15]. We had to exclude
nine patients with clinical manifestations of IDH who
ab
Figure 1 A typical patient with IDH showing exudative
dermatitis with crusting on the face, scalp, external ear, and
retro-auricular areas. a. also demonstrates crusted lesions on face
together with blepharitis that characterises IDH in most patients.
b. Shows an exudative dermatitis with crusting on the face, scalp,
external ear, and retro-auricular areas.
a
b
c
Figure 2 Another patient with infective dermatitis,
presenting with only some of the clinical features of IDH.
a: Infective dermatitis patient with corneal opacities (b) that affect
a proportion of patients with this condition, also demonstrating
flexural involvement (c).
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adults whereas IDH is considered a childhood disease.
However, there have been case reports of IDH beginning
in adult life [16,17]. The lack of a published scoring sys-
tem to assess severity of lesions in IDH makes compari-
son of the clinical appearances of lesions in those co-
infected with HIV-1, difficult. It was therefore difficult
to determine whether the co-infected cases were truly
IDH, or HIV-related seborrhoeic dermatitis.
Except for the absence of anemia in our study popula-
tion in contrast to the previous reports, other laboratory
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mented in the previous descriptions.
The data show that cases of IDH had a significantly
high HTLV-1 proviral load (mean levels of 10.5%). It has
been suggested that IDH act as a cofactor for the devel-
opment of HTLV-1- associated diseases, such as HAM/
TSP and ATLL but the mechanisms are still unclear.
HTLV-1 proviral load levels is regarded as important
predictor of ATLL and HAM/TSP. It would be interest-
ing to follow all the identified cases with IDH over time
and monitor the clinical evolution of the disease to de-
termine if they develop any of the HTLV-1 associated
conditions (ATLL, HAM/TSP).Conclusions
IDH is a distinct entity that affects the African popula-
tion of KwaZulu Natal, South Africa. It is predominantly
a disease of childhood. The clinical features were in
keeping with other series worldwide. Some differences in
presentation are noted, particularly later age of onset
and less nasal discharge. Interplay between genetic fac-
tors and environmental (including socioeconomy and
climate) factors, may determine the age of presentation,
severity of lesions and therefore explain the variation of
IDH presentations between countries. The currect IDH
criteria, needs revision. Crusting of the anterior nares
should not be mandatory. The revised criteria should
take into consideration the heterogeity this disease might
have between different geographical locations.
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